{
  "id": 28366,
  "title": "As US measles cases rise, biotech firms start developing new treatments",
  "url": "https://urgent.news/2026/07/28/as-us-measles-cases-rise-biotech-firms-start-developing-new-treatments",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-28T13:32:23.000Z",
  "source": {
    "name": "Ars Technica Health",
    "slug": "ars-technica-health",
    "url": "https://arstechnica.com/health/2026/07/as-us-measles-cases-rise-biotech-firms-start-developing-new-treatments/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The US is making measles great again, so treatment options are needed for the most vulnerable.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}